Koers Shaanxi Kanghui Pharmaceutical Co., Ltd.
Aandelen
603139
CNE100002XT3
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,77 CNY | -2,30% | -19,94% | -31,97% |
15/03 | Kanghui Pharmaceutical verdient 151 miljoen yuan aan terugkoop Kelavi | MT |
2023 | Kanghui Pharma bestraft wegens het niet openbaar maken van fusie- en overnamedeal | MT |
Omzet 2021 | 443 mln. 61,16 mln. 57,4 mln. | Omzet 2022 | 492 mln. 67,89 mln. 63,72 mln. | Marktkapitalisatie | 1,77 mld. 245 mln. 230 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 36 mln. 4,97 mln. 4,67 mln. | Nettowinst (verlies) 2022 | -63 mln. -8,7 mln. -8,17 mln. | EV/omzet 2021 | 5,3 x |
Nettoschuld 2021 | 172 mln. 23,75 mln. 22,29 mln. | Nettoschuld 2022 | 313 mln. 43,24 mln. 40,59 mln. | EV/omzet 2022 | 4,24 x |
K/w-verhouding 2021 |
58,8
x | K/w-verhouding 2022 |
-28,2
x | Werknemers | 828 |
Dividendrendement 2021 |
0,34% | Dividendrendement 2022 |
-
| Vrij verhandelbaar | 39,72% |
1 dag | -2,30% | ||
1 week | -19,94% | ||
Lopende maand | -16,59% | ||
1 maand | -16,10% | ||
3 maanden | -27,07% | ||
6 maanden | -35,54% | ||
Lopend jaar | -31,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yan Ling Wang
CEO | Chief Executive Officer | 64 | 01-01-99 |
Bin Ze Zou
DFI | Director of Finance/CFO | 37 | 11-12-18 |
Jin Yang
BRD | Director/Board Member | 48 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jian Ping Hou
BRD | Director/Board Member | 63 | 11-12-09 |
Wai Tao Ye
BRD | Director/Board Member | 51 | 01-11-12 |
Yan Ling Wang
CEO | Chief Executive Officer | 64 | 01-01-99 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 12,77 | -2,30% | 1 782 000 |
18-04-24 | 13,07 | -2,39% | 2 108 102 |
17-04-24 | 13,39 | +3,32% | 2 406 300 |
16-04-24 | 12,96 | -10,00% | 1 905 400 |
15-04-24 | 14,4 | -10,00% | 4 134 300 |
slotkoers Shanghai S.E., 19 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-31,97% | 180 mln. | |
+20,91% | 43,54 mld. | |
+16,96% | 21,74 mld. | |
+9,05% | 13,53 mld. | |
+7,98% | 13,02 mld. | |
+33,80% | 11,28 mld. | |
-11,05% | 6,99 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+6,64% | 5,09 mld. |